Autopsy report · NCT02145039
Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
Cause of deathOther
“Replaced by another study.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 4 years 3 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Sponsor type
- University, hospital or other
- Conditions
- Acute Leukemias; Burkitt's Lymphoma; Chronic Myelogenous Leukemia
- Interventions
- Fludarabine; Cyclophosphamide; Total Body Irradiation; Haploidentical stem cell transplant
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
“Replaced with another study” - Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
“replaced by a new study” - Study of Body Composition Methodology in Young Children (InfantPod)
“This study will not be conducted. A new study is replacing this one.” - Estimate Serum Oxytocin PD Range in the Periphery
“Study will be replaced by a revised study protocol” - Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
“The study was incorporated in another study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.